Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oropharyngeal Neoplasms | 30 | 2023 | 491 | 7.940 |
Why?
|
Head and Neck Neoplasms | 61 | 2024 | 2895 | 6.050 |
Why?
|
Free Tissue Flaps | 18 | 2024 | 331 | 4.370 |
Why?
|
Laryngectomy | 13 | 2023 | 243 | 3.540 |
Why?
|
Carcinoma, Squamous Cell | 38 | 2023 | 4026 | 3.510 |
Why?
|
Thyroidectomy | 13 | 2023 | 907 | 3.370 |
Why?
|
Papillomavirus Infections | 21 | 2024 | 1613 | 2.820 |
Why?
|
Neck | 15 | 2023 | 734 | 2.680 |
Why?
|
Robotics | 14 | 2017 | 819 | 2.660 |
Why?
|
Surgical Flaps | 15 | 2021 | 1671 | 2.500 |
Why?
|
Parotid Neoplasms | 5 | 2024 | 157 | 2.480 |
Why?
|
Neck Dissection | 11 | 2023 | 201 | 2.420 |
Why?
|
Natural Orifice Endoscopic Surgery | 8 | 2021 | 119 | 2.320 |
Why?
|
Pharyngeal Diseases | 4 | 2019 | 134 | 1.810 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 7 | 2021 | 324 | 1.750 |
Why?
|
Tongue Neoplasms | 7 | 2023 | 183 | 1.670 |
Why?
|
Papillomaviridae | 14 | 2024 | 1119 | 1.630 |
Why?
|
Otolaryngology | 6 | 2018 | 693 | 1.620 |
Why?
|
Microsurgery | 5 | 2018 | 795 | 1.500 |
Why?
|
Deglutition Disorders | 7 | 2023 | 625 | 1.480 |
Why?
|
Mouth | 10 | 2021 | 381 | 1.420 |
Why?
|
Pharyngectomy | 4 | 2016 | 44 | 1.360 |
Why?
|
Head | 7 | 2022 | 924 | 1.280 |
Why?
|
Parotid Gland | 4 | 2024 | 175 | 1.250 |
Why?
|
Endoscopy | 7 | 2021 | 1851 | 1.240 |
Why?
|
Surgery, Oral | 3 | 2014 | 130 | 1.110 |
Why?
|
Laryngeal Neoplasms | 6 | 2017 | 514 | 1.080 |
Why?
|
Postoperative Complications | 28 | 2024 | 15631 | 1.080 |
Why?
|
Alphapapillomavirus | 6 | 2022 | 218 | 1.070 |
Why?
|
Paranasal Sinus Neoplasms | 4 | 2023 | 242 | 0.980 |
Why?
|
Facial Nerve | 2 | 2024 | 277 | 0.910 |
Why?
|
Oral Surgical Procedures | 4 | 2021 | 166 | 0.900 |
Why?
|
Fibula | 5 | 2024 | 266 | 0.840 |
Why?
|
Cutaneous Fistula | 2 | 2013 | 79 | 0.820 |
Why?
|
Parathyroidectomy | 2 | 2020 | 242 | 0.750 |
Why?
|
Pharynx | 2 | 2014 | 432 | 0.750 |
Why?
|
Nasal Septum | 3 | 2006 | 130 | 0.710 |
Why?
|
Airway Obstruction | 2 | 2018 | 661 | 0.710 |
Why?
|
Rhytidoplasty | 1 | 2021 | 71 | 0.700 |
Why?
|
Nose Neoplasms | 2 | 2021 | 249 | 0.690 |
Why?
|
Education | 2 | 2013 | 537 | 0.670 |
Why?
|
Sialometaplasia, Necrotizing | 1 | 2019 | 6 | 0.670 |
Why?
|
Computer-Assisted Instruction | 2 | 2013 | 362 | 0.660 |
Why?
|
Larynx, Artificial | 3 | 2017 | 69 | 0.650 |
Why?
|
Mouth Neoplasms | 6 | 2023 | 596 | 0.640 |
Why?
|
Speech Disorders | 2 | 2021 | 180 | 0.640 |
Why?
|
Anastomosis, Surgical | 3 | 2017 | 983 | 0.630 |
Why?
|
Humans | 163 | 2024 | 761504 | 0.630 |
Why?
|
Parathyroid Glands | 2 | 2018 | 518 | 0.620 |
Why?
|
Vascular Surgical Procedures | 3 | 2018 | 1489 | 0.620 |
Why?
|
Leeching | 1 | 2018 | 6 | 0.610 |
Why?
|
Deglutition | 3 | 2022 | 208 | 0.610 |
Why?
|
Patient Care Planning | 2 | 2021 | 908 | 0.610 |
Why?
|
Nose Deformities, Acquired | 1 | 2018 | 44 | 0.600 |
Why?
|
Surgery, Computer-Assisted | 3 | 2014 | 1007 | 0.600 |
Why?
|
Glossectomy | 3 | 2023 | 60 | 0.590 |
Why?
|
Tongue | 8 | 2023 | 403 | 0.580 |
Why?
|
Tracheostomy | 4 | 2023 | 426 | 0.580 |
Why?
|
Comprehension | 1 | 2023 | 621 | 0.580 |
Why?
|
Arteries | 4 | 2022 | 1123 | 0.560 |
Why?
|
Thyroid Diseases | 2 | 2017 | 386 | 0.560 |
Why?
|
Radiation Oncology | 1 | 2023 | 563 | 0.560 |
Why?
|
Scapula | 1 | 2018 | 173 | 0.550 |
Why?
|
Hyperemia | 1 | 2018 | 221 | 0.540 |
Why?
|
Pharyngeal Neoplasms | 2 | 2014 | 113 | 0.530 |
Why?
|
Postoperative Care | 3 | 2017 | 1468 | 0.530 |
Why?
|
Fibrin Tissue Adhesive | 2 | 2007 | 86 | 0.520 |
Why?
|
Retrospective Studies | 48 | 2024 | 80636 | 0.510 |
Why?
|
Temporal Bone | 2 | 2024 | 683 | 0.500 |
Why?
|
Antithrombins | 1 | 2018 | 294 | 0.490 |
Why?
|
Middle Aged | 73 | 2024 | 220895 | 0.490 |
Why?
|
Skin Transplantation | 2 | 2018 | 1083 | 0.490 |
Why?
|
Salvage Therapy | 7 | 2018 | 1264 | 0.480 |
Why?
|
Pain, Postoperative | 2 | 2020 | 1739 | 0.470 |
Why?
|
Jugular Veins | 1 | 2015 | 210 | 0.470 |
Why?
|
Hypopharynx | 2 | 2019 | 53 | 0.460 |
Why?
|
Palatine Tonsil | 1 | 2014 | 193 | 0.440 |
Why?
|
Endoscopes | 1 | 2014 | 168 | 0.440 |
Why?
|
Male | 88 | 2024 | 360804 | 0.420 |
Why?
|
Laser Therapy | 2 | 2012 | 1092 | 0.420 |
Why?
|
Thyroid Neoplasms | 4 | 2023 | 2332 | 0.410 |
Why?
|
Nasopharyngeal Neoplasms | 3 | 2023 | 290 | 0.400 |
Why?
|
Neoplasm Staging | 18 | 2024 | 11121 | 0.400 |
Why?
|
Graft Survival | 5 | 2018 | 3819 | 0.400 |
Why?
|
Cadaver | 6 | 2019 | 1358 | 0.400 |
Why?
|
Tumor Virus Infections | 1 | 2014 | 438 | 0.390 |
Why?
|
Skull Base | 1 | 2014 | 292 | 0.380 |
Why?
|
Nasopharynx | 1 | 2014 | 401 | 0.380 |
Why?
|
Tonsillectomy | 3 | 2016 | 278 | 0.380 |
Why?
|
Female | 81 | 2024 | 392644 | 0.380 |
Why?
|
Tonsillar Neoplasms | 1 | 2011 | 50 | 0.380 |
Why?
|
Human papillomavirus 16 | 4 | 2017 | 267 | 0.380 |
Why?
|
Carcinoma | 4 | 2016 | 2330 | 0.360 |
Why?
|
Salivary Glands | 1 | 2012 | 229 | 0.360 |
Why?
|
Dissection | 3 | 2024 | 298 | 0.360 |
Why?
|
Aged | 51 | 2024 | 169289 | 0.360 |
Why?
|
Intubation, Intratracheal | 1 | 2018 | 1329 | 0.350 |
Why?
|
Internship and Residency | 4 | 2018 | 5880 | 0.350 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2010 | 81 | 0.350 |
Why?
|
DNA, Viral | 9 | 2024 | 2202 | 0.340 |
Why?
|
Tracheal Stenosis | 1 | 2012 | 228 | 0.340 |
Why?
|
Monitoring, Physiologic | 1 | 2017 | 1779 | 0.330 |
Why?
|
Laryngoscopy | 3 | 2011 | 706 | 0.330 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2021 | 9280 | 0.330 |
Why?
|
Equipment Failure | 1 | 2012 | 578 | 0.330 |
Why?
|
Adenoma, Pleomorphic | 2 | 2024 | 75 | 0.330 |
Why?
|
Feasibility Studies | 6 | 2020 | 5247 | 0.330 |
Why?
|
Epistaxis | 2 | 2007 | 112 | 0.320 |
Why?
|
Combined Modality Therapy | 9 | 2021 | 8529 | 0.310 |
Why?
|
Tongue Diseases | 1 | 2009 | 68 | 0.310 |
Why?
|
Length of Stay | 10 | 2021 | 6425 | 0.310 |
Why?
|
Rhabdomyosarcoma | 1 | 2011 | 358 | 0.310 |
Why?
|
Clinical Competence | 5 | 2018 | 4792 | 0.310 |
Why?
|
Hospital Costs | 1 | 2014 | 947 | 0.300 |
Why?
|
Device Removal | 2 | 2017 | 630 | 0.300 |
Why?
|
Adult | 46 | 2024 | 221177 | 0.300 |
Why?
|
Education, Medical, Undergraduate | 1 | 2017 | 1070 | 0.300 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 2009 | 93 | 0.300 |
Why?
|
Enteral Nutrition | 2 | 2016 | 794 | 0.280 |
Why?
|
Epiglottis | 2 | 2017 | 81 | 0.280 |
Why?
|
Surgical Wound Infection | 4 | 2022 | 1527 | 0.270 |
Why?
|
Dysphonia | 1 | 2009 | 144 | 0.270 |
Why?
|
Cicatrix | 2 | 2023 | 798 | 0.260 |
Why?
|
Cone-Beam Computed Tomography | 3 | 2015 | 474 | 0.260 |
Why?
|
Peptide Fragments | 1 | 2018 | 5112 | 0.250 |
Why?
|
Laparoscopy | 1 | 2017 | 2035 | 0.240 |
Why?
|
Curriculum | 2 | 2016 | 3743 | 0.240 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2007 | 141 | 0.240 |
Why?
|
Radiotherapy, Intensity-Modulated | 3 | 2016 | 801 | 0.240 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3808 | 0.230 |
Why?
|
Treatment Outcome | 20 | 2024 | 64680 | 0.230 |
Why?
|
Lymphatic Metastasis | 3 | 2022 | 2915 | 0.230 |
Why?
|
Hemostatics | 1 | 2007 | 241 | 0.230 |
Why?
|
Facial Nerve Diseases | 1 | 2004 | 49 | 0.220 |
Why?
|
Aged, 80 and over | 19 | 2022 | 58976 | 0.220 |
Why?
|
Thyroid Gland | 4 | 2018 | 1168 | 0.220 |
Why?
|
Growth Substances | 1 | 2005 | 768 | 0.210 |
Why?
|
Prospective Studies | 16 | 2021 | 54425 | 0.210 |
Why?
|
Risk Assessment | 10 | 2021 | 23995 | 0.210 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2004 | 134 | 0.210 |
Why?
|
Mandible | 4 | 2016 | 753 | 0.210 |
Why?
|
Patient Discharge | 2 | 2021 | 3443 | 0.200 |
Why?
|
Esophageal Stenosis | 1 | 2023 | 196 | 0.200 |
Why?
|
Nasal Cavity | 2 | 2021 | 304 | 0.200 |
Why?
|
Cartilage | 1 | 2005 | 806 | 0.190 |
Why?
|
Cross-Sectional Studies | 7 | 2022 | 26125 | 0.190 |
Why?
|
Joint Instability | 1 | 2009 | 801 | 0.190 |
Why?
|
Quality of Life | 7 | 2023 | 13367 | 0.190 |
Why?
|
Fistula | 2 | 2013 | 212 | 0.190 |
Why?
|
Weight-Bearing | 1 | 2024 | 532 | 0.190 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2014 | 1875 | 0.180 |
Why?
|
Academic Medical Centers | 1 | 2011 | 2759 | 0.180 |
Why?
|
Speech | 2 | 2023 | 554 | 0.180 |
Why?
|
Cause of Death | 1 | 2011 | 3683 | 0.180 |
Why?
|
Prognosis | 16 | 2021 | 29625 | 0.180 |
Why?
|
Radiotherapy, Adjuvant | 3 | 2020 | 1784 | 0.180 |
Why?
|
Heme Oxygenase (Decyclizing) | 2 | 1998 | 167 | 0.180 |
Why?
|
Hospital Mortality | 1 | 2014 | 5294 | 0.180 |
Why?
|
Blood-Brain Barrier | 2 | 1998 | 1027 | 0.170 |
Why?
|
Chondrocytes | 1 | 2005 | 795 | 0.170 |
Why?
|
Antibiotic Prophylaxis | 3 | 2022 | 636 | 0.170 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2004 | 592 | 0.170 |
Why?
|
Cervical Plexus | 1 | 2019 | 16 | 0.170 |
Why?
|
Orthognathic Surgical Procedures | 1 | 2021 | 118 | 0.170 |
Why?
|
Disease-Free Survival | 6 | 2017 | 6814 | 0.170 |
Why?
|
Societies, Medical | 3 | 2021 | 3905 | 0.160 |
Why?
|
Models, Biological | 1 | 2015 | 9469 | 0.160 |
Why?
|
Cartilage, Articular | 1 | 2006 | 1099 | 0.160 |
Why?
|
Databases as Topic | 1 | 2021 | 473 | 0.160 |
Why?
|
Gastrostomy | 3 | 2017 | 323 | 0.160 |
Why?
|
Anti-Infective Agents, Local | 1 | 2021 | 247 | 0.160 |
Why?
|
Neurilemmoma | 1 | 2004 | 526 | 0.160 |
Why?
|
Maryland | 2 | 2016 | 277 | 0.160 |
Why?
|
Maxilla | 1 | 2021 | 494 | 0.150 |
Why?
|
United States | 14 | 2022 | 72334 | 0.150 |
Why?
|
Neoplasm Invasiveness | 6 | 2023 | 3595 | 0.150 |
Why?
|
Palate | 1 | 2018 | 124 | 0.150 |
Why?
|
Nose | 2 | 2019 | 521 | 0.150 |
Why?
|
Cervical Vertebrae | 1 | 2024 | 980 | 0.150 |
Why?
|
Nasal Mucosa | 1 | 2021 | 416 | 0.150 |
Why?
|
Lymph Nodes | 4 | 2017 | 3466 | 0.150 |
Why?
|
Extracellular Matrix | 1 | 2005 | 1726 | 0.150 |
Why?
|
Positive-Pressure Respiration | 1 | 2021 | 639 | 0.140 |
Why?
|
Laryngeal Diseases | 1 | 2020 | 243 | 0.140 |
Why?
|
Laryngoplasty | 1 | 2017 | 50 | 0.140 |
Why?
|
Radiation Injuries | 2 | 2018 | 1189 | 0.140 |
Why?
|
Perception | 1 | 2023 | 1197 | 0.140 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2019 | 262 | 0.140 |
Why?
|
Disease Management | 2 | 2019 | 2508 | 0.140 |
Why?
|
Hirudins | 1 | 2018 | 179 | 0.140 |
Why?
|
Thailand | 1 | 2017 | 287 | 0.140 |
Why?
|
Equipment Design | 2 | 2017 | 3510 | 0.140 |
Why?
|
Immunohistochemistry | 8 | 2019 | 11076 | 0.130 |
Why?
|
Survival Analysis | 6 | 2016 | 10090 | 0.130 |
Why?
|
Reoperation | 6 | 2018 | 4303 | 0.130 |
Why?
|
Clavicle | 1 | 2018 | 224 | 0.130 |
Why?
|
Neoplasms, Unknown Primary | 2 | 2016 | 101 | 0.130 |
Why?
|
North America | 2 | 2017 | 1276 | 0.130 |
Why?
|
Accessory Nerve | 1 | 2015 | 11 | 0.130 |
Why?
|
Cohort Studies | 9 | 2024 | 41487 | 0.130 |
Why?
|
Credentialing | 1 | 2016 | 116 | 0.130 |
Why?
|
Forearm | 2 | 2023 | 427 | 0.130 |
Why?
|
Hospitals, University | 1 | 2017 | 563 | 0.130 |
Why?
|
Case-Control Studies | 6 | 2023 | 22176 | 0.120 |
Why?
|
Swine | 3 | 2015 | 5915 | 0.120 |
Why?
|
Speech Intelligibility | 1 | 2015 | 79 | 0.120 |
Why?
|
Republic of Korea | 1 | 2017 | 590 | 0.120 |
Why?
|
Ultrasonography, Doppler | 1 | 2017 | 462 | 0.120 |
Why?
|
DNA, Neoplasm | 3 | 2015 | 1745 | 0.120 |
Why?
|
Chickens | 1 | 2017 | 859 | 0.120 |
Why?
|
SEER Program | 3 | 2020 | 1450 | 0.120 |
Why?
|
Intubation, Gastrointestinal | 1 | 2016 | 166 | 0.120 |
Why?
|
Axilla | 1 | 2017 | 624 | 0.120 |
Why?
|
Learning Curve | 2 | 2018 | 230 | 0.120 |
Why?
|
Surgical Wound Dehiscence | 1 | 2015 | 213 | 0.120 |
Why?
|
Incidence | 7 | 2019 | 21353 | 0.120 |
Why?
|
Video-Assisted Surgery | 1 | 2014 | 51 | 0.120 |
Why?
|
Surgical Instruments | 1 | 2017 | 383 | 0.120 |
Why?
|
Periosteum | 1 | 2015 | 139 | 0.120 |
Why?
|
Time Factors | 7 | 2021 | 39967 | 0.110 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2015 | 103 | 0.110 |
Why?
|
Young Adult | 10 | 2024 | 59243 | 0.110 |
Why?
|
Adolescent | 10 | 2024 | 88319 | 0.110 |
Why?
|
Models, Anatomic | 2 | 2015 | 683 | 0.110 |
Why?
|
Positron-Emission Tomography | 3 | 2016 | 6485 | 0.110 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2017 | 323 | 0.110 |
Why?
|
Microvessels | 1 | 2018 | 577 | 0.110 |
Why?
|
Neoplasms, Nerve Tissue | 1 | 2013 | 21 | 0.110 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 1995 | 397 | 0.110 |
Why?
|
Multivariate Analysis | 4 | 2017 | 12059 | 0.110 |
Why?
|
Finite Element Analysis | 1 | 2015 | 438 | 0.110 |
Why?
|
Adenoma | 1 | 2004 | 2160 | 0.110 |
Why?
|
Glycosaminoglycans | 2 | 2006 | 607 | 0.110 |
Why?
|
Analysis of Variance | 3 | 2011 | 6228 | 0.100 |
Why?
|
Carbolines | 1 | 2015 | 296 | 0.100 |
Why?
|
Salivation | 1 | 2012 | 22 | 0.100 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2019 | 2010 | 0.100 |
Why?
|
Esthetics | 1 | 2014 | 330 | 0.100 |
Why?
|
Hashimoto Disease | 1 | 2013 | 105 | 0.100 |
Why?
|
Skull Base Neoplasms | 1 | 2016 | 270 | 0.100 |
Why?
|
Salivary Gland Neoplasms | 1 | 2016 | 304 | 0.100 |
Why?
|
Treatment Failure | 1 | 2018 | 2645 | 0.100 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3514 | 0.100 |
Why?
|
Dehydration | 1 | 2013 | 216 | 0.100 |
Why?
|
Rhabdomyosarcoma, Alveolar | 1 | 2011 | 42 | 0.100 |
Why?
|
Follow-Up Studies | 7 | 2014 | 39106 | 0.100 |
Why?
|
Time and Motion Studies | 1 | 2011 | 143 | 0.090 |
Why?
|
Baltimore | 1 | 2011 | 231 | 0.090 |
Why?
|
In Situ Hybridization | 4 | 2016 | 1900 | 0.090 |
Why?
|
Saliva | 1 | 2015 | 828 | 0.090 |
Why?
|
Internet | 1 | 2023 | 3092 | 0.090 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2011 | 100 | 0.090 |
Why?
|
Surgical Staplers | 1 | 2010 | 34 | 0.090 |
Why?
|
Stress, Mechanical | 1 | 2015 | 1674 | 0.090 |
Why?
|
Radial Artery | 1 | 2011 | 187 | 0.090 |
Why?
|
Quality Assurance, Health Care | 1 | 2020 | 2169 | 0.090 |
Why?
|
Thyroid Nodule | 1 | 2017 | 764 | 0.090 |
Why?
|
Human papillomavirus 11 | 1 | 2009 | 14 | 0.080 |
Why?
|
Postoperative Hemorrhage | 1 | 2013 | 415 | 0.080 |
Why?
|
Risk Factors | 9 | 2022 | 74206 | 0.080 |
Why?
|
Respiratory Tract Neoplasms | 1 | 2009 | 56 | 0.080 |
Why?
|
Proportional Hazards Models | 5 | 2017 | 12463 | 0.080 |
Why?
|
Aorta, Thoracic | 1 | 2015 | 1096 | 0.080 |
Why?
|
Phantoms, Imaging | 2 | 2015 | 2526 | 0.080 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2011 | 156 | 0.080 |
Why?
|
Ultrasonography, Interventional | 1 | 2017 | 1496 | 0.080 |
Why?
|
Intraoperative Period | 1 | 2010 | 510 | 0.080 |
Why?
|
Practice Guidelines as Topic | 2 | 2016 | 7390 | 0.080 |
Why?
|
Radiotherapy | 2 | 2021 | 1499 | 0.080 |
Why?
|
Stroboscopy | 1 | 2009 | 62 | 0.080 |
Why?
|
Disability Evaluation | 1 | 2016 | 1835 | 0.080 |
Why?
|
Immunity, Cellular | 1 | 2015 | 1560 | 0.080 |
Why?
|
Linear Models | 2 | 2020 | 5871 | 0.080 |
Why?
|
Cysts | 1 | 2014 | 681 | 0.080 |
Why?
|
Papilloma | 1 | 2009 | 140 | 0.080 |
Why?
|
Patient Satisfaction | 1 | 2021 | 3461 | 0.080 |
Why?
|
Bone Transplantation | 1 | 2013 | 929 | 0.080 |
Why?
|
Regression Analysis | 2 | 2017 | 6343 | 0.080 |
Why?
|
Carcinoma, Papillary | 1 | 2013 | 785 | 0.080 |
Why?
|
Radiopharmaceuticals | 2 | 2016 | 2651 | 0.080 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6534 | 0.070 |
Why?
|
Soft Tissue Injuries | 1 | 2009 | 172 | 0.070 |
Why?
|
Voice Quality | 1 | 2009 | 226 | 0.070 |
Why?
|
Immunoglobulin G | 2 | 1998 | 4544 | 0.070 |
Why?
|
Sarcoma | 1 | 2018 | 1801 | 0.070 |
Why?
|
Endopeptidase K | 1 | 2006 | 23 | 0.070 |
Why?
|
Pain Measurement | 1 | 2017 | 3550 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 5 | 2016 | 20570 | 0.070 |
Why?
|
Postoperative Period | 3 | 2018 | 1813 | 0.070 |
Why?
|
Intensive Care Units | 2 | 2017 | 3745 | 0.070 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2011 | 464 | 0.070 |
Why?
|
Osmotic Pressure | 2 | 1998 | 138 | 0.070 |
Why?
|
Ultrasonography | 2 | 2017 | 5972 | 0.070 |
Why?
|
Program Development | 1 | 2012 | 1297 | 0.070 |
Why?
|
Voice Disorders | 1 | 2009 | 286 | 0.070 |
Why?
|
Compressive Strength | 1 | 2006 | 158 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2373 | 0.060 |
Why?
|
Tissue Engineering | 2 | 2006 | 1868 | 0.060 |
Why?
|
Guideline Adherence | 1 | 2016 | 2220 | 0.060 |
Why?
|
Antibodies, Viral | 1 | 2017 | 3156 | 0.060 |
Why?
|
Logistic Models | 3 | 2016 | 13255 | 0.060 |
Why?
|
Hydrolysis | 1 | 2006 | 664 | 0.060 |
Why?
|
Survivors | 1 | 2016 | 2371 | 0.060 |
Why?
|
Animals | 8 | 2017 | 168459 | 0.060 |
Why?
|
Graft Rejection | 2 | 2018 | 4445 | 0.060 |
Why?
|
Predictive Value of Tests | 6 | 2019 | 15266 | 0.060 |
Why?
|
Carotid Arteries | 1 | 2009 | 941 | 0.060 |
Why?
|
Tensile Strength | 1 | 2005 | 330 | 0.060 |
Why?
|
Cell Membrane Permeability | 1 | 2006 | 575 | 0.060 |
Why?
|
Early Ambulation | 1 | 2024 | 49 | 0.060 |
Why?
|
Pilot Projects | 3 | 2023 | 8631 | 0.060 |
Why?
|
Voice | 1 | 2007 | 268 | 0.060 |
Why?
|
Probability | 1 | 2009 | 2477 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3688 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2014 | 2917 | 0.060 |
Why?
|
Radiation Dosage | 1 | 2012 | 1958 | 0.060 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2005 | 343 | 0.060 |
Why?
|
Biopsy | 2 | 2014 | 6766 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2023 | 5821 | 0.050 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2005 | 592 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8002 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3416 | 0.050 |
Why?
|
Patient Readmission | 2 | 2016 | 3270 | 0.050 |
Why?
|
Anisotropy | 1 | 2006 | 1283 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2017 | 698 | 0.050 |
Why?
|
Antisepsis | 1 | 2022 | 16 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3639 | 0.050 |
Why?
|
Physicians | 1 | 2020 | 4591 | 0.050 |
Why?
|
Melanoma | 1 | 2021 | 5709 | 0.050 |
Why?
|
Comorbidity | 2 | 2014 | 10508 | 0.050 |
Why?
|
Dilatation | 1 | 2023 | 306 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2009 | 2426 | 0.050 |
Why?
|
Sensation | 1 | 2023 | 337 | 0.050 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2005 | 629 | 0.050 |
Why?
|
Embolization, Therapeutic | 2 | 2009 | 1418 | 0.050 |
Why?
|
Patient Positioning | 1 | 2024 | 326 | 0.050 |
Why?
|
DNA Methylation | 1 | 2015 | 4398 | 0.050 |
Why?
|
Oropharynx | 1 | 2021 | 138 | 0.040 |
Why?
|
Enzyme Induction | 2 | 1998 | 452 | 0.040 |
Why?
|
Child | 6 | 2024 | 80153 | 0.040 |
Why?
|
Neuroglia | 2 | 1996 | 956 | 0.040 |
Why?
|
Health Care Costs | 1 | 2013 | 3242 | 0.040 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2005 | 842 | 0.040 |
Why?
|
Radius | 1 | 2023 | 441 | 0.040 |
Why?
|
Sex Distribution | 2 | 2016 | 2281 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1096 | 0.040 |
Why?
|
Databases, Factual | 2 | 2014 | 7967 | 0.040 |
Why?
|
Temperature | 1 | 2006 | 2226 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2009 | 2825 | 0.040 |
Why?
|
Sural Nerve | 1 | 2019 | 105 | 0.040 |
Why?
|
Age Distribution | 2 | 2016 | 2880 | 0.040 |
Why?
|
Palate, Soft | 1 | 2019 | 100 | 0.040 |
Why?
|
Survival Rate | 3 | 2021 | 12725 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9420 | 0.040 |
Why?
|
Computer Simulation | 1 | 2012 | 6240 | 0.040 |
Why?
|
Clinical Protocols | 1 | 2024 | 1440 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 3 | 2015 | 17904 | 0.040 |
Why?
|
Collagen | 1 | 2006 | 2638 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2015 | 4811 | 0.040 |
Why?
|
Prolapse | 1 | 2017 | 63 | 0.040 |
Why?
|
Nerve Transfer | 1 | 2019 | 128 | 0.040 |
Why?
|
Transforming Growth Factor beta | 1 | 2005 | 1961 | 0.040 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2005 | 1934 | 0.040 |
Why?
|
Software | 1 | 2011 | 4434 | 0.040 |
Why?
|
Sex Factors | 3 | 2017 | 10552 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 3 | 1998 | 8181 | 0.040 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2017 | 109 | 0.030 |
Why?
|
Perioperative Care | 1 | 2024 | 1033 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 2 | 1998 | 2469 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2013 | 9000 | 0.030 |
Why?
|
Mutation | 3 | 2015 | 30052 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6484 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2009 | 3889 | 0.030 |
Why?
|
Heme Oxygenase-1 | 1 | 1998 | 366 | 0.030 |
Why?
|
Age Factors | 3 | 2020 | 18395 | 0.030 |
Why?
|
Oncogene Proteins, Viral | 1 | 2017 | 340 | 0.030 |
Why?
|
Mannitol | 1 | 1995 | 180 | 0.030 |
Why?
|
Fixatives | 1 | 2015 | 90 | 0.030 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2015 | 32 | 0.030 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2016 | 140 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2019 | 736 | 0.030 |
Why?
|
Immunoblotting | 1 | 1998 | 1646 | 0.030 |
Why?
|
Hospitalization | 1 | 2014 | 10723 | 0.030 |
Why?
|
Therapeutic Irrigation | 1 | 2015 | 292 | 0.030 |
Why?
|
Gastroscopy | 1 | 2016 | 211 | 0.030 |
Why?
|
Amines | 1 | 2016 | 281 | 0.030 |
Why?
|
Quality of Health Care | 1 | 2009 | 4330 | 0.030 |
Why?
|
Kinetics | 1 | 2022 | 6374 | 0.030 |
Why?
|
Paraffin Embedding | 1 | 2015 | 302 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2015 | 241 | 0.030 |
Why?
|
Cleft Palate | 1 | 2019 | 589 | 0.030 |
Why?
|
Formaldehyde | 1 | 2015 | 358 | 0.030 |
Why?
|
Drinking | 1 | 2014 | 198 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18252 | 0.030 |
Why?
|
Ear Auricle | 1 | 2012 | 31 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 1995 | 1705 | 0.030 |
Why?
|
Radiotherapy, Conformal | 1 | 2016 | 548 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2018 | 2927 | 0.030 |
Why?
|
Esophagectomy | 1 | 2016 | 468 | 0.030 |
Why?
|
Rats | 3 | 1998 | 23742 | 0.030 |
Why?
|
Radiotherapy, High-Energy | 1 | 2012 | 228 | 0.020 |
Why?
|
Hemostasis, Surgical | 1 | 2012 | 126 | 0.020 |
Why?
|
Needs Assessment | 1 | 2018 | 1139 | 0.020 |
Why?
|
Bronchoscopy | 1 | 2017 | 909 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3123 | 0.020 |
Why?
|
Seroma | 1 | 2011 | 75 | 0.020 |
Why?
|
Osteoradionecrosis | 1 | 2011 | 51 | 0.020 |
Why?
|
Metagenome | 1 | 2014 | 450 | 0.020 |
Why?
|
Hypocalcemia | 1 | 2011 | 200 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2015 | 1008 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2005 | 18965 | 0.020 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2016 | 1141 | 0.020 |
Why?
|
Preoperative Period | 1 | 2011 | 551 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7212 | 0.020 |
Why?
|
Thigh | 1 | 2010 | 241 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2014 | 1118 | 0.020 |
Why?
|
Analgesics | 1 | 2016 | 1070 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2015 | 1400 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2017 | 20098 | 0.020 |
Why?
|
Child, Preschool | 1 | 2011 | 42230 | 0.020 |
Why?
|
Vocal Cord Paralysis | 1 | 2011 | 272 | 0.020 |
Why?
|
Prevalence | 2 | 2016 | 15732 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2015 | 1742 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2017 | 2421 | 0.020 |
Why?
|
Smoking | 2 | 2014 | 9053 | 0.020 |
Why?
|
Vocal Cords | 1 | 2011 | 522 | 0.020 |
Why?
|
Hematoma | 1 | 2011 | 768 | 0.020 |
Why?
|
Face | 1 | 2012 | 1026 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2015 | 2020 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2017 | 2986 | 0.020 |
Why?
|
Disease Progression | 2 | 2015 | 13506 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4575 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2015 | 2735 | 0.020 |
Why?
|
Radiology | 1 | 2019 | 2113 | 0.020 |
Why?
|
Brain Injuries | 1 | 1996 | 2053 | 0.010 |
Why?
|
Critical Care | 1 | 2017 | 2696 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2013 | 3162 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2015 | 4915 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 2009 | 1204 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2011 | 2115 | 0.010 |
Why?
|
Blood Pressure | 2 | 1996 | 8481 | 0.010 |
Why?
|
Gene Expression | 1 | 1995 | 7581 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7407 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2013 | 5869 | 0.010 |
Why?
|
Fees, Medical | 1 | 2002 | 111 | 0.010 |
Why?
|
Ligation | 1 | 2002 | 448 | 0.010 |
Why?
|
Wound Healing | 1 | 2011 | 2805 | 0.010 |
Why?
|
Contrast Media | 1 | 2012 | 5311 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2014 | 12795 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2013 | 4580 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1995 | 9177 | 0.010 |
Why?
|
Genomics | 1 | 2014 | 5821 | 0.010 |
Why?
|
Calcium | 1 | 2011 | 5722 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10194 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16591 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2002 | 1668 | 0.010 |
Why?
|
Neurons | 1 | 1995 | 9463 | 0.010 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 1996 | 553 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12974 | 0.010 |
Why?
|
Algorithms | 1 | 2013 | 14031 | 0.010 |
Why?
|
Oligodendroglia | 1 | 1996 | 538 | 0.010 |
Why?
|
Brain | 1 | 1996 | 27112 | 0.010 |
Why?
|
Cerebellum | 1 | 1996 | 1501 | 0.010 |
Why?
|
Astrocytes | 1 | 1996 | 1346 | 0.000 |
Why?
|
Microglia | 1 | 1996 | 1361 | 0.000 |
Why?
|
Cerebral Cortex | 1 | 1996 | 5777 | 0.000 |
Why?
|